NSPR - InspireMD, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
3,530
3,601
2,761
1,894
Cost of Revenue
2,806
2,606
2,176
1,792
Gross Profit
724
995
585
102
Operating Expenses
Research Development
3,069
1,535
1,276
1,291
Selling General and Administrative
7,171
7,071
7,541
6,459
Total Operating Expenses
10,240
8,606
8,817
7,750
Operating Income or Loss
-9,516
-7,611
-8,232
-7,648
Interest Expense
-
-
179
812
Total Other Income/Expenses Net
-
-
-
-812
Income Before Tax
-9,696
-7,240
-8,411
-8,460
Income Tax Expense
0
0
27
1
Income from Continuing Operations
-9,696
-7,240
-8,438
-8,461
Net Income
-9,696
-7,240
-8,438
-8,461
Net Income available to common shareholders
-9,745
-7,696
-13,028
-8,461
Reported EPS
Basic
-
-16.50
-1.75k
-10.04k
Diluted
-
-16.50
-1.75k
-10.04k
Weighted average shares outstanding
Basic
-
462
7
1
Diluted
-
462
7
1
EBITDA
-
-7,611
-8,232
-7,648